LY2969822

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY2969822, covering 2019-02-21 to 2019-02-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY2969822 in Healthy Participants [Phase 1]